Adooq Bioscience

Adooq Bioscience logo

AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.

Company Website

Product Listing

P7C3 50mg 50mg  | Purity Not Available

Adooq Bioscience

P7C3 is neurogenic and protects new neurons against apoptosis. It protects newborn neurons in the dentate gyrus and stimulates the growth of new neurons.

More Information Supplier Page

Paclitaxel (Taxol) 100mg 100mg  | Purity Not Available

Adooq Bioscience

Paclitaxel (Taxol) is a mitotic inhibitor that stabilizes microtubules and as a result, interferes with the normal breakdown of microtubules during cell division.

More Information Supplier Page

Paclitaxel (Taxol) 10mg 10mg  | Purity Not Available

Adooq Bioscience

Paclitaxel (Taxol) is a mitotic inhibitor that stabilizes microtubules and as a result, interferes with the normal breakdown of microtubules during cell division.

More Information Supplier Page

Paclitaxel (Taxol) 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

Paclitaxel (Taxol) is a mitotic inhibitor that stabilizes microtubules and as a result, interferes with the normal breakdown of microtubules during cell division.

More Information Supplier Page

Paclitaxel (Taxol) 200mg 200mg  | Purity Not Available

Adooq Bioscience

Paclitaxel (Taxol) is a mitotic inhibitor that stabilizes microtubules and as a result, interferes with the normal breakdown of microtubules during cell division.

More Information Supplier Page

Paclitaxel (Taxol) 50mg 50mg  | Purity Not Available

Adooq Bioscience

Paclitaxel (Taxol) is a mitotic inhibitor that stabilizes microtubules and as a result, interferes with the normal breakdown of microtubules during cell division.

More Information Supplier Page

Pacritinib (SB1518) 10mg 10mg  | Purity Not Available

Adooq Bioscience

Pacritinib, also known as SB1518, is an orally bioavailable inhibitor of Janus kinase 2 (JAK2) and the JAK2 mutant JAK2V617F with potential antineoplastic activity. Pacritinib competes with JAK2 for ATP binding, which may result in inhibition of JAK2 activation, inhibition of the JAK-STAT signaling pathway, and so caspase-dependent apoptosis.

More Information Supplier Page

Pacritinib (SB1518) 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

Pacritinib, also known as SB1518, is an orally bioavailable inhibitor of Janus kinase 2 (JAK2) and the JAK2 mutant JAK2V617F with potential antineoplastic activity. Pacritinib competes with JAK2 for ATP binding, which may result in inhibition of JAK2 activation, inhibition of the JAK-STAT signaling pathway, and so caspase-dependent apoptosis.

More Information Supplier Page

Pacritinib (SB1518) 25mg 25mg  | Purity Not Available

Adooq Bioscience

Pacritinib, also known as SB1518, is an orally bioavailable inhibitor of Janus kinase 2 (JAK2) and the JAK2 mutant JAK2V617F with potential antineoplastic activity. Pacritinib competes with JAK2 for ATP binding, which may result in inhibition of JAK2 activation, inhibition of the JAK-STAT signaling pathway, and so caspase-dependent apoptosis.

More Information Supplier Page

Pacritinib (SB1518) 50mg 50mg  | Purity Not Available

Adooq Bioscience

Pacritinib, also known as SB1518, is an orally bioavailable inhibitor of Janus kinase 2 (JAK2) and the JAK2 mutant JAK2V617F with potential antineoplastic activity. Pacritinib competes with JAK2 for ATP binding, which may result in inhibition of JAK2 activation, inhibition of the JAK-STAT signaling pathway, and so caspase-dependent apoptosis.

More Information Supplier Page

Pacritinib (SB1518) 5mg 5mg  | Purity Not Available

Adooq Bioscience

Pacritinib, also known as SB1518, is an orally bioavailable inhibitor of Janus kinase 2 (JAK2) and the JAK2 mutant JAK2V617F with potential antineoplastic activity. Pacritinib competes with JAK2 for ATP binding, which may result in inhibition of JAK2 activation, inhibition of the JAK-STAT signaling pathway, and so caspase-dependent apoptosis.

More Information Supplier Page

Pafuramidine 10mg 10mg  | Purity Not Available

Adooq Bioscience

Pafuramidine is an orally bioavailable prodrug of furamidine, which has clinical activity against Pneumocystis pneumonia.

More Information Supplier Page

Pafuramidine 50mg 50mg  | Purity Not Available

Adooq Bioscience

Pafuramidine is an orally bioavailable prodrug of furamidine, which has clinical activity against Pneumocystis pneumonia.

More Information Supplier Page

Pafuramidine 5mg 5mg  | Purity Not Available

Adooq Bioscience

Pafuramidine is an orally bioavailable prodrug of furamidine, which has clinical activity against Pneumocystis pneumonia.

More Information Supplier Page